Asosiy kontentga oʻtish
AkademScholar

Kashfiyot

Xizmatlar

Identifikatsiya

Ishlab chiquvchilar uchun

Ekotizim

Muassasalar

The University of Texas MD Anderson Cancer Center

Davlat:
US
ROR:
https://ror.org/04twxam07
7
h-indeks
469
Iqtiboslar
172
Asarlar
742
Mualliflar
Vaqt boʻyicha

Vaqt boʻyicha tahlil

Iqtibos sharhi

Yillar boʻyicha nashrlar (ustun) va iqtiboslar (chiziq)

  • Nashrlar
  • Iqtiboslar
0510152005010015020020172018201920202021202220232024202520262017: Nashrlar 18, Iqtiboslar 92018: Nashrlar 16, Iqtiboslar 192019: Nashrlar 8, Iqtiboslar 112020: Nashrlar 18, Iqtiboslar 132021: Nashrlar 7, Iqtiboslar 172022: Nashrlar 7, Iqtiboslar 432023: Nashrlar 12, Iqtiboslar 592024: Nashrlar 2, Iqtiboslar 632025: Nashrlar 4, Iqtiboslar 982026: Nashrlar 0, Iqtiboslar 121

Iqtibos tarixi

05010015020020172018201920202021202220232024202520262017: Iqtiboslar 92018: Iqtiboslar 192019: Iqtiboslar 112020: Iqtiboslar 132021: Iqtiboslar 172022: Iqtiboslar 432023: Iqtiboslar 592024: Iqtiboslar 632025: Iqtiboslar 982026: Iqtiboslar 121

Nashr tarixi

0510152020172018201920202021202220232024202520262017: Nashrlar 182018: Nashrlar 162019: Nashrlar 82020: Nashrlar 182021: Nashrlar 72022: Nashrlar 72023: Nashrlar 122024: Nashrlar 22025: Nashrlar 42026: Nashrlar 0

h-indeks evolyutsiyasi

Yillar boʻyicha jamlangan h-indeks

03581020172018201920202021202220232024202520262017: h-indeks 32018: h-indeks 32019: h-indeks 32020: h-indeks 32021: h-indeks 32022: h-indeks 32023: h-indeks 42024: h-indeks 52025: h-indeks 52026: h-indeks 7

Eng koʻp iqtibos qilingan asarlar

  1. Recent developments regarding the use of thieno[2,3-d]pyrimidin-4-one derivatives in medicinal chemistry, with a focus on their synthesis and anticancer properties201516 iqtibos
  2. Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study20202 iqtibos
  3. Progress and remaining challenges for cancer control in Latin America and the Caribbean20151 iqtibos
  4. Core elements of national cancer control plans: a tool to support plan development and review20191 iqtibos
  5. Late mortality and chronic health conditions in long-term survivors of early-adolescent and young adult cancers: a retrospective cohort analysis from the Childhood Cancer Survivor Study20201 iqtibos
  6. Value of Positron Emission Tomography in Staging Ocular Adnexal Lymphomas and Evaluating Their Response to Therapy20070 iqtibos
  7. Bone Windows for Distinguishing Malignant from Benign Primary Bone Tumors on FDG PET/CT20130 iqtibos
  8. POSTER: CML-491 Case Report of Variant Translocations and Atypical BCR::ABL Transcripts in CML Management20230 iqtibos
  9. POSTER: CML-449 JAK2-Unmutated Erythrocytosis in Chronic Phase Myeloid Leukemia (CP-CML) During Tyrosine Kinase Inhibitor (TKI) Treatment20230 iqtibos
  10. POSTER: CML-319 Molecular Response of ≤10% BCR::ABL1IS Is Predictive of Positive Outcomes in Patients With Treatment-Resistant Chronic-Phase Chronic Myeloid Leukemia (CP-CML) Treated With Ponatinib From the Phase 2 OPTIC Trial20230 iqtibos